APOLLO 8
APOLLO 8, officially known as Aenova Group, is a leading player in the pharmaceutical and healthcare industry, headquartered in Switzerland (CH). Founded in 2011, the company has rapidly established itself as a key provider of high-quality contract manufacturing services, specialising in the production of solid, semi-solid, and liquid dosage forms. With a strong operational presence across Europe and North America, APOLLO 8 is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of pharmaceutical products, which are distinguished by their adherence to stringent regulatory standards and advanced manufacturing processes. Notable achievements include significant partnerships with major pharmaceutical firms, positioning APOLLO 8 as a trusted partner in the global market. With a focus on sustainability and efficiency, APOLLO 8 continues to drive advancements in the industry, making it a formidable force in contract manufacturing.
DitchCarbon Score
How does APOLLO 8's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
APOLLO 8's score of 6 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
APOLLO 8's reported carbon emissions
APOLLO 8 currently does not have any available carbon emissions data for recent years. However, the company is actively engaged in climate commitments, particularly in the pharmaceutical sector. While specific reduction targets have not been disclosed, it is noted that APOLLO 8 is committed to near-term climate action, aligning with industry standards for sustainability. The company is part of a broader movement within the pharmaceuticals, biotechnology, and life sciences sectors, which are increasingly focusing on reducing their carbon footprints. This includes efforts to address Scope 1, 2, and 3 emissions, although specific details on these scopes for APOLLO 8 are not provided. As the company continues to develop its climate strategy, stakeholders can expect future announcements regarding specific targets and initiatives aimed at reducing carbon emissions and enhancing sustainability practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
APOLLO 8 is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
